Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Heron Therapeutics, Inc.

NASDAQ: HRTX · Life Sciences · 4 alerts · CIK 818033

Share price
$0.2843Close, Nov 16
Market cap
$54.1M
Shares outstanding
190.27MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Heron Therapeutics, Inc. filings on SEC EDGAR ↗

7:41 AM ET 8-K
Divestiture

Heron Therapeutics Divestiture to CorMedix Inc. for $145M

Heron Therapeutics has entered into a definitive agreement to sell substantially all of its assets to CorMedix Inc. for $145 million in cash and 14,583,333 shares of CorMedix common stock. The deal includes Heron's commercial portfolio (ZYNRELEF, APONVIE, CINVANTI, and SUSTOL) and provides for up to $55 million in potential earn-out payments plus royalties. Heron will remain a standalone public company, using the proceeds to repay its existing debt and evaluate new strategic investments.

Value
$145M
Counterparty
CorMedix Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.